Targeted Radionuclide Therapy for Metastatic Melanoma [131I] ICF01012

NCT03784625 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Melanoma

Interventions

DRUG: [131I]ICF01012 (therapeutic dose level 1)
DRUG: [131I]ICF01012 (therapeutic dose level 2)
DRUG: [131I]ICF01012 (therapeutic dose level 3)
DRUG: [131I]ICF01012 (therapeutic dose level 4)

Sponsor

Centre Jean Perrin